TABLE 2.
Cities | Date | Serotype | ITD | Sequence |
|||
---|---|---|---|---|---|---|---|
5′NCR | VP1 | VP1/2A | 3D | ||||
Parma | June 2005 | PV3 | SL | 472 U > C | |||
Naples | May 2007 | PV3 | SL | 472 U > C | |||
473 C > U | |||||||
Milan | September 2007 | PV2 | SL | 481 A > G | 2487 T > C | Recombinant S2/S1 | |
2736 T > C | |||||||
Milan | April 2008 | PV2 | SL | 325 U > C | 2909 T> C | 6147 T > C | |
481 A > G | 6213 G > A | ||||||
6285 C > T | |||||||
Palermo | June 2008 | PV3 | SL | 472 U > C | 2637 C > T | Recombinant S3/S2 |
5′NCR, nt 179 to 575; VP1, nt 2482 to 3384 for PV2 and nt 2477 to 3376 for PV3; VP1/2A, nt 3241 to 3460; 3D, nt 6086 to 6376. ITD, intratypic differentiation.